I-Ensitrelvir (S-217622) I-CAS 1360105-53-8 Ubumsulwa >98.0% Isithombe Esifakiwe se-COVID-19

I-Ensitrelvir (S-217622) I-CAS 1360105-53-8 Ubumsulwa >98.0% COVID-19

Incazelo emfushane:

Igama Lekhemikhali: 1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)-

I-CAS: 1360105-53-8

Ubumsulwa: >98.0% (HPLC)

I-Intermediate ye-Ensitrelvir (S-217622), COVID-19

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Commercial Supply Ensitrelvir (S-217622) Emaphakathi:
I-S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
I-Trimethyloxonium Tetrafluoroborate CAS 420-37-1
I-6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8

Chemical Properties:

Igama Lekhemikhali	1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)-
Omqondofana	3-tert-butyl-6-(ethylthio)-1,3,5-triazine-2,4(1H,3H)-dione
Inombolo ye-CAS	1360105-53-8
Inombolo yeCAT	I-RF-PI1504
Isimo Sesitoko	Kukhona kusitoki
I-Molecular Formula	I-C9H15N3O2S
Isisindo samangqamuzana	229.3
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ubumsulwa	>98.0%
Ukulahlekelwa Ekumisweni	<1.00%
Ukungcola Okuphelele	<2.00%
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Intermediate ye-Ensitrelvir (S-217622), COVID-19

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

I-FAQ:

Isicelo:

I-3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride (CAS: 135206-76-7) iphakathi kwe-Ensitrelvir (S-217622).I-Ensitrelvir isidakamizwa esilwa namagciwane esakhiwe yi-Shionogi ngokubambisana neNyuvesi yase-Hokkaido, esisebenza njenge-3C-like protease inhibitor esebenza ngomlomo ekwelapheni ukutheleleka nge-COVID-19.Ithathwa ngomlomo, futhi ihlolwe ngempumelelo ngokuhluka okusanda kuvela kwe-Omicron.Yaba iphilisi lokuqala lasekhaya laseJapan ukwelapha i-COVID-19, okwesithathu ukugunyazwa ngokomthetho eJapan;ngoFebhuwari 2022.